Abstract
Aims
To access the impact of increasing use of metformin on cesarean section and large for gestational age rates, when compared to insulin.
Methods
A retrospective observational study was developed using data from the Portuguese National Registry, between 2011 and 2019, of 5038 Portuguese women with single pregnancies and gestational diabetes treated with metformin and/or insulin. Three groups were defined according to the therapeutic regimen adopted: g1–insulin in monotherapy (n = 3027[60.1%]); g2–metformin in monotherapy (n = 1366[27.1%]); g3–metformin and insulin (n = 645[12.8%]). Multivariate analysis was adjusted for statistically significant covariates.
Results
The cesarean section rate in g1 was similar to g2 (g1:36.9% vs. g2:37%, p = 0.982), although g3 was associated with cesarean delivery (g3:43.6% vs. g1:36.9%, p = 0.005; g3:43.6% vs. g1:37.0%, p = 0.002), with no differences reported in the multivariate analysis adjusted for year of delivery and pregestational body mass index. A delivery of a large for gestational age newborn was less frequently observed in g2 than in g1 (g2:4.1% vs. g1:5.4%, p = 0.044) and in g3 (g2:4.1% vs. g3:9.1%, p < 0.001), and in g1, when compared to g3 (g1:5.4% vs. g3:9.1%, p < 0.001). In the multivariate analysis, g2 showed lower odds of delivering a large for gestational age newborn, compared to g1 (β = −0.511, OR = 0.596, CI95% = 0.428–0.832, p < 0.001).
Conclusions
The use of metformin was not associated with higher cesarean section rates, compared to insulin. Instead, it was suggested a protective role of metformin on large gestational age rates. The concomitant use of dual therapy suggests more complex pregnancies, requiring closer surveillance that mitigate serious perinatal and obstetrical outcomes.
Similar content being viewed by others
References
ACOG Practice Bulletin No (2018) 190: gestational diabetes mellitus. Obstet Gynecol 131(2):e49–e64. https://doi.org/10.1097/AOG.0000000000002501
Dickens LT, Thomas CC (2019) Updates in gestational diabetes prevalence, treatment, and health policy. Curr Diab Rep 19(6):33. https://doi.org/10.1007/s11892-019-1147-0
Stogianni A, Lendahls L, Landin-Olsson M, Thunander M (2019) Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden. BMC Preg Childbirth 19(1):159. https://doi.org/10.1186/s12884-019-2269-8
Ovesen PG, Jensen DM, Damm P, Rasmussen S, Kesmodel US (2015) Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. A nation-wide study. J Matern Fetal Neonatal Med 28(14):1720–1724. https://doi.org/10.3109/14767058.2014.966677
Wang J, Pan L, Liu E, Liu H, Liu J, Wang S, Guo J, Li N, Zhang C, Hu G (2019) Gestational diabetes and offspring’s growth from birth to 6 years old. Int J Obes (Lond) 43(4):663–672. https://doi.org/10.1038/s41366-018-0193-z
Almeida M, Dores J, Ruas L (2017) Consenso diabetes gestacional: atualização 2017 [Consensus on gestational diabetes: 2017 update]. Rev Port Diabetes 12(1):24–38
Tarry-Adkins JL, Aiken CE, Ozanne SE (2019) Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med 16(8):e1002848. https://doi.org/10.1371/journal.pmed.1002848
Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R (2015) Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 350:h102. https://doi.org/10.1136/bmj.h102
In: Rasmussen KM, Yaktine AL, (editors) (2009) Weight gain during pregnancy: reexamining the guidelines. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC)
International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 33(3):676–82. https://doi.org/10.2337/dc09-1848
Group HSCR, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002. https://doi.org/10.1056/NEJMoa0707943
Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13:59. https://doi.org/10.1186/1471-2431-13-59
IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp
Pazzagli L, Abdi L, Kieler H, Cesta CE (2020) Metformin versus insulin use for treatment of gestational diabetes and delivery by caesarean section: a nationwide Swedish cohort study. Eur J Obstet Gynecol Reprod Biol 254:271–276. https://doi.org/10.1016/j.ejogrb.2020.09.037
Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, Raudaskoski T (2011) Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 118(7):880–885. https://doi.org/10.1111/j.1471-0528.2010.02763.x
Ijas H, Vaarasmaki M, Saarela T, Keravuo R, Raudaskoski T (2015) A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG 122(7):994–1000. https://doi.org/10.1111/1471-0528.12964
Wouldes TA, Battin M, Coat S, Rush EC, Hague WM, Rowan JA (2016) Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal Neonatal Ed 101(6):F488–F493. https://doi.org/10.1136/archdischild-2015-309602
Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM (2011) Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 34(10):2279–2284. https://doi.org/10.2337/dc11-0660
Parrettini S, Caroli A, Torlone E (2020) Nutrition and metabolic adaptations in physiological and complicated pregnancy: focus on obesity and gestational diabetes. Front Endocrinol (Lausanne) 11:611929. https://doi.org/10.3389/fendo.2020.611929
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH (2018) The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. https://doi.org/10.3390/ijms19113342
Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Broms G, Einarsdottir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad O, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I (2019) Antidiabetic medication use during pregnancy: an international utilization study. BMJ Open Diabetes Res Care 7(1):e000759. https://doi.org/10.1136/bmjdrc-2019-000759
World Health Organization (2021) Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [accessed 27 March 2022]
Power ML, Schulkin J (2008) Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr 99(5):931–940. https://doi.org/10.1017/S0007114507853347
Funding
The authors declare that they have no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.
Author information
Authors and Affiliations
Consortia
Contributions
Conceptualization: DR, SC; Methodology: DR, SC, RR, HA, LA; Formal analysis and investigation: DR, GR, EF, SM, MJO, MCA; Writing—original draft preparation: DR, SC, RR, HA, LA; Writing—review and editing: GR, EF, SM, MJO, MCA; Resources: DR, MJO, MCA; Supervision: GR, EF, SM, MJO, MCA. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent to participate
All the persons gave their informed consent prior to their inclusion in the analysis.
Ethical approval
This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Each participating hospital’s institutional ethics committee has approved the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini.
Rights and permissions
About this article
Cite this article
Ramalho, D., Correia, S., Realista, R. et al. Impact of pharmacological treatment of gestational diabetes on the mode of delivery and birth weight: a nationwide population-based study on a subset of singleton pregnant Portuguese women. Acta Diabetol 59, 1361–1368 (2022). https://doi.org/10.1007/s00592-022-01931-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-022-01931-x